Source:http://linkedlifedata.com/resource/pubmed/id/17513615
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2007-5-21
|
pubmed:abstractText |
Previous studies have indicated that d,l-sulforaphane (SFN), a synthetic cancer chemopreventive analogue of cruciferous vegetable-derived isomer (-)-1-isothiocyanato-(4R)-(methylsulfinyl)-butane, activates a checkpoint kinase 2 (Chk2)-dependent G(2)-M phase cell cycle arrest in p53-deficient human prostate cancer cells. Because p53 is a downstream target of Chk2 kinase and known to regulate G(2)-M transition by transcriptional regulation of cyclin-dependent kinase (Cdk) inhibitor p21(Cip1/Waf1) (p21), the present study was undertaken to determine the role of p21 in SFN-induced cell cycle arrest using wild-type p53-expressing cell line LNCaP. The SFN treatment caused a modest increase in S phase fraction and a marked increase in G(2)-M fraction in LNCaP cells in a concentration- and time-dependent manner. The SFN-induced S phase arrest correlated with a reduction in protein levels of cyclin D1, cyclin E, Cdk4, and Cdk6, whereas activation of the G(2)-M checkpoint was accompanied by induction of cyclin B1 and down-regulation of Cdk1 and Cdc25C protein levels. The SFN-treated LNCaP cells were also arrested in mitosis as revealed by immunofluorescence microscopy and increased Ser(10) phosphorylation of histone H3, a sensitive marker for mitotic cells. The SFN treatment increased activating phosphorylation of Chk2 (Thr(68)) that was accompanied by induction of p53 and p21. The SFN-induced mitotic arrest was statistically significantly increased by small interfering RNA-based knockdown of p21. However, p21 protein knockdown did not have any appreciable effect on SFN-induced cytoplasmic histone-associated DNA fragmentation (apoptosis). In conclusion, the present study indicates that induction of p21 protects against SFN-induced mitotic arrest in LNCaP cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticarcinogenic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Histones,
http://linkedlifedata.com/resource/pubmed/chemical/TP53 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Thiocyanates,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53,
http://linkedlifedata.com/resource/pubmed/chemical/sulforafan
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1535-7163
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1673-81
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17513615-Anticarcinogenic Agents,
pubmed-meshheading:17513615-Cell Cycle,
pubmed-meshheading:17513615-Cell Division,
pubmed-meshheading:17513615-Cell Line, Tumor,
pubmed-meshheading:17513615-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:17513615-G2 Phase,
pubmed-meshheading:17513615-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17513615-Histones,
pubmed-meshheading:17513615-Humans,
pubmed-meshheading:17513615-Male,
pubmed-meshheading:17513615-Microscopy, Fluorescence,
pubmed-meshheading:17513615-Mitosis,
pubmed-meshheading:17513615-Prostatic Neoplasms,
pubmed-meshheading:17513615-Thiocyanates,
pubmed-meshheading:17513615-Tumor Suppressor Protein p53
|
pubmed:year |
2007
|
pubmed:articleTitle |
Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line.
|
pubmed:affiliation |
Department of Molecular Biology, University of Gdask, Gdask, Poland.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|